Published in Neurol Res Int on March 11, 2012
Maternal Immunoreactivity to Herpes Simplex Virus 2 and Risk of Autism Spectrum Disorder in Male Offspring. mSphere (2017) 1.21
Influence of infection during pregnancy on fetal development. Reproduction (2013) 1.20
Contrasting pediatric and adult cerebral malaria: the role of the endothelial barrier. Virulence (2013) 0.96
Prevalence of bloodstream pathogens is higher in neonatal encephalopathy cases vs. controls using a novel panel of real-time PCR assays. PLoS One (2014) 0.87
Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome. PLoS Negl Trop Dis (2016) 0.84
Role of immunoglobulin in neuronal apoptosis in a neonatal rat model of hypoxic ischemic brain injury. Exp Ther Med (2014) 0.82
Effect of dexamethasone administered with magnesium sulfate on inflammation-mediated degradation of the blood-brain barrier using an in vitro model. Reprod Sci (2013) 0.81
Protective ventilation of preterm lambs exposed to acute chorioamnionitis does not reduce ventilation-induced lung or brain injury. PLoS One (2014) 0.81
Specific Lipopolysaccharide Serotypes Induce Differential Maternal and Neonatal Inflammatory Responses in a Murine Model of Preterm Labor. Am J Pathol (2015) 0.81
Elevated plasma and cerebrospinal fluid interleukin-1 beta and tumor necrosis factor-alpha concentration and combined outcome of death or abnormal neuroimaging in preterm neonates with early-onset clinical sepsis. J Perinatol (2015) 0.80
Nanomedicine in cerebral palsy. Int J Nanomedicine (2013) 0.80
Hypothermia modulates cytokine responses after neonatal rat hypoxic-ischemic injury and reduces brain damage. ASN Neuro (2014) 0.79
Proton magnetic resonance spectroscopy and outcome in term neonates with chorioamnionitis. J Perinatol (2015) 0.76
Neutralizing anti-interleukin-1β antibodies reduce ischemia-related interleukin-1β transport across the blood-brain barrier in fetal sheep. Neuroscience (2017) 0.75
Perinatal Brain Injury As a Consequence of Preterm Birth and Intrauterine Inflammation: Designing Targeted Stem Cell Therapies. Front Neurosci (2017) 0.75
Novel Wavelet Real Time Analysis of Neurovascular Coupling in Neonatal Encephalopathy. Sci Rep (2017) 0.75
Ischemia reduces inter-alpha inhibitor proteins in the brain of the ovine fetus. Dev Neurobiol (2016) 0.75
Murine model: maternal administration of stem cells for prevention of prematurity. Am J Obstet Gynecol (2014) 0.75
Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery. Exp Ther Med (2017) 0.75
Systemic infusions of anti-interleukin-1β neutralizing antibodies reduce short-term brain injury after cerebral ischemia in the ovine fetus. Brain Behav Immun (2017) 0.75
The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med (1985) 12.23
Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci (2006) 12.23
Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics (2010) 9.15
Intrauterine infection and preterm delivery. N Engl J Med (2000) 8.48
Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol (2009) 6.90
Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell (2004) 6.15
Proinflammatory cytokines. Chest (2000) 5.89
Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol (2007) 5.20
Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature (2001) 4.35
Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res (2001) 3.94
Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA (2000) 3.62
The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci (2002) 3.55
Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics (2005) 3.06
Cerebral palsy. Lancet (2004) 2.65
Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol (2003) 2.65
Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA (2003) 2.49
Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol (1993) 2.46
Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr Res (2003) 2.41
Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants. Pediatrics (2002) 2.39
Cerebral white matter injury of the premature infant-more common than you think. Pediatrics (2003) 2.35
Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol (2000) 2.30
Chorioamnionitis and cerebral palsy: a meta-analysis. Obstet Gynecol (2010) 2.30
Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia (2010) 2.23
Systemic inflammation disrupts the developmental program of white matter. Ann Neurol (2011) 2.20
Annual summary of vital statistics: 2008. Pediatrics (2010) 2.19
Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide. Brain Behav Immun (2005) 2.18
Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke (2010) 2.18
The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol (2009) 2.12
The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol (1993) 2.12
Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology (2001) 2.09
Effects of melatonin treatment in septic newborns. Pediatr Res (2001) 1.99
Melatonin signaling and cell protection function. FASEB J (2010) 1.99
The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J Immunol (2006) 1.94
Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer (2007) 1.81
Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest (1990) 1.81
Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol (1996) 1.79
Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest (1991) 1.77
Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes. Ann Neurol (2005) 1.77
Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol Pharmacol (2006) 1.76
Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci (2007) 1.76
The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol (2000) 1.74
Infection and labor. III. Interleukin-1: a signal for the onset of parturition. Am J Obstet Gynecol (1989) 1.72
Interleukin-6 genotype and risk for cerebral palsy in term and near-term infants. Ann Neurol (2009) 1.69
The management of brain edema in brain tumors. Curr Opin Oncol (2004) 1.67
Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol (2004) 1.64
Toll-like receptors. Curr Protoc Immunol (2007) 1.64
Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res Dev Brain Res (2003) 1.63
Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol (1989) 1.62
Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review. Histol Histopathol (2004) 1.61
Cerebral magnetic resonance biomarkers in neonatal encephalopathy: a meta-analysis. Pediatrics (2010) 1.60
Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine (2005) 1.59
Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke (2007) 1.59
Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol (1991) 1.59
Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Developmental Epidemiology Network Investigators. Pediatr Res (1999) 1.58
Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci (2007) 1.58
Association between high cytokine levels with white matter injury in preterm infants with sepsis. Pediatr Crit Care Med (2012) 1.52
Development of the choroid plexus. Microsc Res Tech (2001) 1.52
Cytokines and perinatal brain damage. Clin Perinatol (2008) 1.50
Barriers in the brain: a renaissance? Trends Neurosci (2008) 1.49
The relationship between early concentrations of 25 blood proteins and cerebral white matter injury in preterm newborns: the ELGAN study. J Pediatr (2011) 1.49
Functional effectiveness of the blood-brain barrier to small water-soluble molecules in developing and adult opossum (Monodelphis domestica). J Comp Neurol (2006) 1.48
A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics (2008) 1.46
Progress in periventricular leukomalacia. Arch Neurol (2008) 1.46
Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des (2005) 1.44
Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol (2005) 1.42
Diffusion tensor imaging in children with periventricular leukomalacia: variability of injuries to white matter tracts. AJNR Am J Neuroradiol (2007) 1.40
Role of innate host defenses in susceptibility to early-onset neonatal sepsis. Clin Perinatol (2010) 1.39
A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats. Pediatr Res (2007) 1.39
Intrauterine infection and the development of cerebral palsy. BJOG (2003) 1.39
Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr Neuropharmacol (2008) 1.38
Unimpaired outcomes for extremely low birth weight infants at 18 to 22 months. Pediatrics (2009) 1.37
Fetal inflammatory response and brain injury in the preterm newborn. J Child Neurol (2009) 1.36
Inflammatory brain damage in preterm newborns--dry numbers, wet lab, and causal inferences. Early Hum Dev (2004) 1.35
Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Mol Psychiatry (1997) 1.35
IP-10 is an early diagnostic marker for identification of late-onset bacterial infection in preterm infants. Pediatr Res (2007) 1.35
Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Res (2001) 1.34
Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS (2011) 1.33
Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglandins (1989) 1.30
Innate and adaptive immune responses of the central nervous system. Crit Rev Immunol (2006) 1.28
The neuroprotective role of inflammation in nervous system injuries. J Neurol (2004) 1.27
Erythropoietin sustains cognitive function and brain volume after neonatal stroke. Dev Neurosci (2009) 1.26
Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience (2009) 1.25
Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF. J Cereb Blood Flow Metab (2008) 1.24
Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke (2005) 1.24
Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr Res (2007) 1.23
Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists. J Endotoxin Res (2005) 1.22
An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics (2008) 1.22
Barriers in the immature brain. Cell Mol Neurobiol (2000) 1.21
Cytokines and brain injury: invited review. J Intensive Care Med (2008) 1.21
The relationship of CSF and plasma cytokine levels to cerebral white matter injury in the premature newborn. Pediatr Res (2004) 1.20
Barrier mechanisms in the brain, II. Immature brain. Clin Exp Pharmacol Physiol (1999) 1.20
Antenatal risk factors for cerebral palsy. Best Pract Res Clin Obstet Gynaecol (2004) 1.19
Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res (2001) 1.17
Neurobiology of injury to the developing brain. Nat Rev Neurol (2010) 1.16
Cytokines and neurodevelopmental outcomes in extremely low birth weight infants. J Pediatr (2011) 1.16
Inflammation in neurological disorders: a help or a hindrance? Neuroscientist (2010) 1.14
Cytokines and anti-cytokines as therapeutics--an update. Eur J Pharmacol (2007) 1.14
Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system. J Neurochem (2011) 1.14
Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol (2005) 1.14
A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats. Pediatr Res (2007) 1.39
Pharmacokinetics of high-dose recombinant erythropoietin in plasma and brain of neonatal rats. Pediatr Res (2007) 1.30
Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics (2012) 1.29
Effects of transfusions in extremely low birth weight infants: a retrospective study. J Pediatr (2009) 1.14
Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia. Dev Neurosci (2013) 1.13
Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr Res (2005) 1.10
Erythropoietin for infants with hypoxic-ischemic encephalopathy. Curr Opin Pediatr (2010) 1.08
Which neuroprotective agents are ready for bench to bedside translation in the newborn infant? J Pediatr (2012) 1.07
Application of comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method to identify potential biomarkers of perinatal asphyxia in a non-human primate model. J Chromatogr A (2011) 0.97
Recent trends in erythropoietin-mediated neuroprotection. Int J Dev Neurosci (2007) 0.97
A new model of neonatal stress which produces lasting neurobehavioral effects in adult rats. Neonatology (2007) 0.96
Neonatal stress or morphine treatment alters adult mouse conditioned place preference. Neonatology (2008) 0.93
Postnatal stress produces hyperglycemia in adult rats exposed to hypoxia-ischemia. Pediatr Res (2009) 0.91
Iron sulfate supplementation decreases zinc protoporphyrin to heme ratio in premature infants. J Pediatr (2006) 0.90
Left ventricular hypertrophy is prevalent in Sprague-Dawley rats. Comp Med (2010) 0.89
Safety of high-dose recombinant erythropoietin in a neonatal rat model. Neonatology (2006) 0.89
Long-term effects of neonatal stress on adult conditioned place preference (CPP) and hippocampal neurogenesis. Behav Brain Res (2011) 0.86
High-dose erythropoietin does not exacerbate retinopathy of prematurity in rats. Pediatr Res (2009) 0.86
High-dose erythropoietin inhibits apoptosis and stimulates proliferation in neonatal rat intestine. Growth Horm IGF Res (2007) 0.86
Perinatal asphyxia in a nonhuman primate model. Dev Neurosci (2011) 0.85
Effects of neonatal stress and morphine on kappa opioid receptor signaling. Neonatology (2009) 0.82
The perinatal transition of the circulating metabolome in a nonhuman primate. Pediatr Res (2012) 0.82
Erythropoietin improved cognitive function and decreased hippocampal caspase activity in rat pups after traumatic brain injury. J Neurotrauma (2014) 0.80
A Critical Review of Models of Perinatal Infection. Dev Neurosci (2015) 0.80
Magnesium is not consistently neuroprotective for perinatal hypoxia-ischemia in term-equivalent models in preclinical studies: a systematic review. Dev Neurosci (2014) 0.80
Erythropoietin in human milk: physiology and role in infant health. J Hum Lact (2002) 0.80
Erythropoietin as a neuroprotectant for neonatal brain injury: animal models. Methods Mol Biol (2013) 0.78
Time course of C-reactive protein and inflammatory mediators after neonatal surgery. J Pediatr (2011) 0.77
The effect of interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) on granulocyte macrophage-colony stimulating factor (GM-CSF) production by neuronal precursor cells. Eur Cytokine Netw (2002) 0.76
Serial plasma metabolites following hypoxic-ischemic encephalopathy in a nonhuman primate model. Dev Neurosci (2015) 0.76
Zinc protoporphyrin-to-heme ratios in high-risk and preterm infants. J Pediatr (2012) 0.76
Adult responses to an ischemic stroke in a rat model of neonatal stress and morphine treatment. Int J Dev Neurosci (2012) 0.75
Hypothermia plus erythropoietin for neonatal neuroprotection? Commentary on Fan et al. and Fang et al. Pediatr Res (2013) 0.75
Long-Term Neuropathological Changes Associated with Cerebral Palsy in a Nonhuman Primate Model of Hypoxic-Ischemic Encephalopathy. Dev Neurosci (2017) 0.75
Characterization of developing bowel transplanted from transgenic erythropoietin receptor-deficient mouse embryos. Neonatology (2007) 0.75
Focal Brain Injury Associated with a Model of Severe Hypoxic-Ischemic Encephalopathy in Nonhuman Primates. Dev Neurosci (2017) 0.75